Substituted nucleotide analogs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9605018
APP PUB NO 20150141363A1
SERIAL NO

14608523

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are phosphorothioate nucleotide analogs, methods of synthesizing phosphorothioate nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the phosphorothioate nucleotide analogs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALIOS BIOPHARMA INC10 SHOREVIEW STREET SAN FRANCISCO CA 94121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beigelman, Leonid San Mateo, US 390 10741
Wang, Guangyi Carlsbad, US 90 3414

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00